pgy2 program
Emergency Medicine

Residency Program Director
  • Erin Reichert, PharmD, BCPS

    • PGY2 Emergency Medicine Residency Program Director The Ohio State University Wexner Medical Center
    • Emergency Medicine Specialist
Previous Year Residents
  • Robert Brenneman, PharmD

    Clinical Pharmacy Specialist, ICU/Emergency Medicine, Grant Hospital
  • Matthew Poremba, PharmD

    Clinical Pharmacy Specialist, Emergency Medicine, University of Maryland, Baltimore
  • Joe Plott

    Clinical Pharmacy Specialist, Emergency Medicine, University Hospital, Newark, New Jersey
  • Ashley Weiner

    Clinical Pharmacy Specialist, Emergency Medicine, The Ohio State Wexner Medical Center
  • Asia Rujevcan

    Emergency Medicine Clinical Pharmacist, University of Chicago Medical Center
  • Caroline Vizzi

    Emergency Medicine Clinical Pharmacist, New York-Presbyterian Hospital
  • Samantha Wagner

    Critical Care Clinical Pharmacist, Emergency Medicine/Critical Care, Denver Health, Denver, CO
  • Lauren Beauchamp

    Emergency Medicine Clinical Pharmacist, Franciscan Health, Indianapolis, IN
  • Elena Ko

    Emergency Medicine Clinical Specialist, Carolina Medical Center, Charlotte, NC
  • Katie Weigartz

    Emergency Medicine Clinical Pharmacist, Baylor University Medical Center, PGY1 Program Director, Dallas, TX
  • Kelsey Billups

    ED Clinical Pharmacist, Medical University of South Carolina
  • Suhair Shawar

    Emergency Department Clinical Pharmacy Specialist, The Ohio State University Wexner Medical Center

About the PGY2 Emergency Medicine Residency Program


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in  specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings.  Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

DSC_8782Residency Sites

As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care. OSUWMC is a 1,506 bed multi-hospital delivery system recognized in 2022 as one of “America’s Best Hospitals” for excellence in nine specialties by US News and World Report based on quality, outcomes, and reputation.

The Abercrombie and Fitch Emergency Department


The Abercrombie and Fitch Emergency Department (ED) at The OSUWMC is a designated Level 1 Trauma Center, as well as a Comprehensive Stroke, Burn, and Hyperbaric Oxygen Treatment Center and Cardiac Center with more than 80,000 visits annually. The ED space includes over 109 beds: nine Level 1 Trauma-Critical Care Resuscitation Rooms, a 20 bed observation Unit, a 15 bed hematology/oncology pod, and an Arrival Zone for minor illness or injury treatment. The Department of Emergency Medicine provides medical staff for this unit, which includes 60 staff physicians and 48 Emergency Medicine (EM) residents. The pharmacist-physician relationship is synergistic and collaborative. The medical team consists of EM staff physicians and residents, advanced practice providers, guest residents from services such as internal medicine, anesthesia, and orthopedics, medical students, EM nurses and nursing students, social workers and their students, clinical case managers, respiratory therapists, psychiatrists.

Key rotations/experiences

Required core rotations include:

  • Orientation
  • Introduction to Triage in Emergency Medicine (4 weeks)
  • Intermediate Triage in Emergency Medicine (4 weeks)
  • Advanced Triage in Emergency Medicine (4-5 weeks)
  • Observation (2 weeks)
  • Psychiatry (2 weeks)
  • Hematology/Oncology in Emergency Medicine (3 weeks)
  • Emergency Medicine IPPE Clinical Precepting (2 weeks)
  • Advanced Emergency Medicine (4-5 weeks)
  • Pediatrics at Nationwide Children’s Hospital (4 weeks)

Required longitudinal rotations include:

  • Clinical and Operational Staffing
  • Journal Club
  • Quality and Medication Safety
  • Research
  • Teaching

Elective learning experiences include but are not limited to:

  • Surgical ICU (3 weeks)
  • Medical ICU (3 weeks)
  • Cardiology (3 weeks)
  • Neuro ICU (2 weeks)
  • Nocturnal Emergency Medicine (2 weeks)
  • Central Ohio Poison Control (2 weeks)
  • Community Emergency Medicine at OSU East Hospital (2 weeks)
  • Emergency Medicine Clinical Precepting (4 weeks)
  • Emergency Medicine – Emergency Preparedness (4 weeks)

The program is designed to develop the resident’s clinical expertise in emergency medicine and provide the necessary skills in teaching, quality improvement, and management of medical emergencies. To improve research abilities, the resident will interact with clinicians with research experience and participate in the Pharmacy Research Series. The PGY2 Emergency Medicine Resident will be expected to design, implement, and prepare a manuscript suitable for publication for their chosen research project. Additional opportunities for research and publication are available if the resident desires.

Other key experiences during the residency will include completion of longitudinal medication safety and quality which includes active reporting and follow up of medication events and 2 quality projects and teaching which includes precepting both IPPE and APPE students from The Ohio State University College of Pharmacy, recorded lecture for Advanced Training in Emergency Medicine medical students at The Ohio State University College of Medicine. Other opportunities for teaching include nursing and physician education in the Department of Emergency Medicine or pre-hospital. Other longitudinal rotations include journal club and operational and clinical staffing weekends throughout the residency year.

The resident will also have the opportunity to attend the ASHP Midyear Clinical Meeting, a second professional meeting or participating in a medical mission trip to Forte Liberte, Haiti, and other local or regional educational seminars/conferences as applicable. The program is flexible and will be designed to meet the needs and goals of the individual.

Key Preceptors

Kelsey Champa, PharmD
Emergency Medicine

Andrew North, MBA, PharmD, BCPS, BCCCP
Emergency Medicine

Erin Reichert, PharmD, BCPS
Emergency Medicine

Elizabeth Rozycki, PharmD, BCPS
Emergency Medicine

Suhair Shawar, PharmD, BCPS
Emergency Medicine

Kimberly Jones, PharmD, BCPS, BCPPS
Nationwide Children’s Hospital
Emergency Medicine

Emilija Stojova, PharmD, BCPS
Emergency Medicine

Selected Resident research

  • An analysis of the relationship between 4-factor prothrombin complex concentrate dose and INR reduction – Plott, J, Reichert E, Emerson G, Li J, North A
  • Comparison of 4-factor prothrombin complex concentrate in obese versus non-obese patients for emergent warfarin reversal – Weiner A, Reichert E, Bischof J, Li J, North A
  • Thromboembolic complications after 4-factor prothrombin complex concentrate in oncology patients – Rujevcan A, Gopal M, Giglio P, Kaide C, Stojova, E, Li J, Reichert E
  • The utilization of a nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction assay performed in the emergency department – Vizzi C, Reichert E, Caterino J, Li J, Rozycki E
  • Fluid resuscitation in septic patients with heart failure and reduced ejection fraction – Beauchamp L, Adkins E, Li J, Rozycki E
  • Thromboembolic complications between 3F-PCC and 4F-PCC for warfarin reversal – Wagner S, Kaide C, Li J, Reichert E
  • Safety of intramuscular ketamine for acute agitation in the ED – Weigartz K, Lester N, Li J, Reichert E
  • Impact of paralytic agent on time to post-intubation sedation in the pre-hospital setting
  • Beta-lactam versus aminoglycoside-based antibiotic prophylaxis therapy for type III open fractures – Shawar S, Ly T, Shirk MB, Li J, Reichert E

Benefits and Additional Requirements

Application Deadline:  December 30

Start Date: July 1

Annual Salary – $48,500

Vacation Days –10 days

Staffing Requirement – 20 weekends per year

Completion of a Major Research Project


Download PDF